Advertisement

Topics

deCODE genetics Inc. Company Profile

04:54 EDT 19th June 2018 | BioPortfolio

In January 2006 deCODE GENETICS Inc., acquired Urdur Verdanki Skuld, a privately-held cancer research firm. The acquisition enables deCODE to broaden and enhances its cancer program by applying deCODE's unique gene discovery and drug development capabilities to an even larger set of population-based resources.

Location

Sturlugata 8
Reykjavik
IS-101
Ireland

Contact

Phone: 354 570 1900
Fax: 354 570 1903
Email: info@decode.is


News Articles [441 Associated News Articles listed on BioPortfolio]

deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15022018] Prices from USD $350

deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investments re...

R&D Head Sean Harper On Amgen's Long-Term Investment View

Amgen is validating targets through the deCODE Genetics investment it made five years and moving drugs into the clinic. It's...   

John E. Sulston, Nobel-winning scientist who helped decode human genome, dies at 75 – Washington Post

Washington PostJohn E. Sulston, Nobel-winning scientist who helped decode human genome, dies at 75Washington PostJohn E. Sulston, a scientist who won the Nobel Prize for work on one of the lowliest of...

Adaptive Biotechnologies and Microsoft Partner to Decode the Human Immune System to Improve Disease Diagnosis

SEATTLE–(BUSINESS WIRE)–Adaptive Biotechnologies, a leader in next-generation sequencing (NGS) of T- and B-cell receptors of the adaptive immune system, announced today their partnership w...

PharmaMar lizensiert vollsynthetisch aus Meeressubstanzen gewonnene Payloads für Wirkstoff-Konjugate an Seattle Genetics

Madrid (ots/PRNewswire) - PharmaMar (MCE: PHM) hat heute die Unterzeichnung einer exklusiven Lizenzvereinbarung mit Seattle Genetics Inc. (SGEN: NASDAQ GS) bekanntgegeben, nach der Seattle Genetics...

Quotidian Technical Highlights on Selected Healthcare Stocks -- Atossa Genetics, Palatin ...

www.wallstequities.com/registration Atossa Genetics On Thursday, shares in Seattle, Washingtonheadquartered Atossa Genetics Inc. recorded a trading volume of 2.03 million shares. The stock ended a...

Climate Change Forces Bird Genetics to Adapt

NewsAs Earth’s climate changes, species must adapt, shift their geographical ranges or face decline and, in some cases, extinction. Using genetics, biologists are racing against time to find out the...

Seattle Genetics To Acquire Cascadian Therapeutics

NewsThe acquisition will enhance Seattle Genetics’ portfolio of solid tumor programs with potential rapid registration pathways and provides global rights to a pivotal Phase 2 program in development...

Drugs and Medications [0 Results]

None

Clinical Trials [313 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes

The results from the DECODE Study have shown that postprandial (1 - 2 hours after a meal) hyperglycemia (elevated blood sugar) is more common in elderly people with diabetes than younger p...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetics of Asthma and Bronchial Hyperresponsiveness

To investigate the genetics of asthma by reexamining a carefully characterized population of patients with asthma, and by studying their families.

Companies [42 Associated Companies listed on BioPortfolio]

deCODE genetics Inc.

In January 2006 deCODE GENETICS Inc., acquired Urdur Verdanki Skuld, a privately-held cancer research firm. The acquisition enables deCODE to broaden and enhances its cancer program by applying deCODE...

deCode

Based in Reykjavik, Iceland, deCODE genetics is a population-based genomics company conducting research into the inherited causes of common diseases. The company operates one of the most technological...

deCODE genetics

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery - our population approach ...

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

deCODE chemistry

deCODE chemistry offers chemistry-based drug discovery and development services including early-stage lead discovery and optimization, process chemistry research for development of optimal synthetic r...

More Information about "deCODE genetics Inc." on BioPortfolio

We have published hundreds of deCODE genetics Inc. news stories on BioPortfolio along with dozens of deCODE genetics Inc. Clinical Trials and PubMed Articles about deCODE genetics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of deCODE genetics Inc. Companies in our database. You can also find out about relevant deCODE genetics Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record